g Mycobacterium tuberculosis contains a single rRNA operon that encodes targets for antituberculosis agents, including kanamycin. To date, only four mutations in the kanamycin binding sites of 16S rRNA have been reported in kanamycin-resistant clinical isolates. We hypothesized that another mutation(s) in the region may dramatically decrease M. tuberculosis viability and virulence. Here, we describe an rRNA mutation, U1406A, which was generated in vitro and confers resistance to kanamycin while highly attenuating M. tuberculosis virulence. The mutant showed decreased expression of 20% (n ‫؍‬ 361) of mycobacterial proteins, including central metabolic enzymes, mycolic acid biosynthesis enzymes, and virulence factors such as antigen 85 complexes and ESAT-6. The mutation also induced three proteins, including KsgA (Rv1010; 16S rRNA adenine dimethyltransferase), which closely bind to the U1406A mutation site on the ribosome; these proteins were associated with ribosome maturation and translation initiation processes. The mutant showed an increase in 17S rRNA (precursor 16S rRNA) and a decrease in the ratio of 30S subunits to the 70S ribosomes, suggesting that the U1406A mutation in 16S rRNA attenuated M. tuberculosis virulence by affecting these processes.
M
ycobacterium tuberculosis causes approximately 9.6 million incident cases of active tuberculosis (TB) and 1.5 million deaths each year (1) . Directly observed short-course chemotherapy with first-line drugs isoniazid, rifampin, pyrazinamide, and ethambutol prevents the emergence of drug resistance in drugsusceptible cases (2) . Treating multidrug-resistant TB (MDR-TB) with second-line drugs may cure Ͼ65% of patients and stop ongoing transmission (2) . Globally, an estimated 3.3% of new TB cases and 20% of previously treated cases have MDR-TB, a level that has changed little in recent years (1) . Extensively drug-resistant TB is defined as MDR-TB that also demonstrates resistance to at least one fluoroquinolone and a second-line injectable drug, such as kanamycin, amikacin, or capreomycin (1, 3) .
High-level kanamycin resistance (MIC, Ն80 g/ml) has been attributed to mutations in the 16S rRNA gene, rrs (4) . Low-level resistance (5 g/ml Ͻ MIC Ͻ 80 g/ml) is thought to be due to promoter mutations in the aminoglycoside acetyltransferase gene, eis (4) . Aminoglycoside antibiotics bind to the A (aminoacyl) site of the ribosomal decoding region (helix 44 of 16S rRNA) (5) and reduce the fidelity of mRNA translation (6) (Fig. 1A) . Although many mutations in the kanamycin binding sites of 16S rRNA that confer resistance to kanamycin can be generated easily in vitro, only four mutations have been reported in clinical isolates: A1408G (corresponding to position 1400 in the rrs gene of M. tuberculosis; A1400G Mtb ), C1409U (C1401U Mtb ), G1491U (G1483U Mtb ), and the double-base change C1409A (C1401A Mtb )/G1491U (7, 8) . The three mutated nucleotides, A1408, C1409, and G1491, are in contact with two rings of kanamycin: the 6-aminoglucose (ring I) and the 2-deoxystreptamine (ring II) (8, 9) . The molecular mechanisms limiting mutated variants in clinical isolates, especially in the nucleotides contacting the other ring of kanamycin, 3-aminoglucose (kanosamine) of ring III, remain to be determined. We hypothesized that this lack of alterations in the nucleotides that bind ring III of kanamycin is due to selection pressure in vivo. Although direct mutagenesis of Mycobacterium smegmatis 16S rRNA showed that certain genetic alterations and compensatory mutations are lethal or confer a high fitness cost in vitro (8) , some mutations that did not induce growth defects in vitro were not reported in clinical isolates. The contributions of these mutations to in vivo selection are therefore not yet understood. Since genome analysis has shown that the M. tuberculosis chromosome contains a single rRNA operon (10), we also hypothesized that a ribosomal mutation directly affects the function because of a lack of compensation by multiple rRNA operons.
Hygromycin B is an aminoglycoside with a unique spiro-acetal structure (9) and binds to the helix 44 region of 16S rRNA, a region immediately adjacent to the decoding loop (9) (Fig. 1A) .
High-resolution crystal structure analysis showed that the binding sites of hygromycin B and 3-aminoglucose of kanamycin overlap (9) . To analyze the effects of mutations in the rRNA decoding region not reported in clinical isolates, we isolated in vitro mutants resistant to both kanamycin and hygromycin B. Although the growth of the mutant in vitro was slightly decreased compared to strain Erdman, the virulence was significantly decreased in mouse TB models. We report here that several virulence factors that are altered by a single mutation in the 16S rRNA gene of M. tuberculosis mediate resistance to aminoglycosides. Bacterial strains and growth conditions. The virulent M. tuberculosis Erdman strain was obtained as previously described (11, 12 Industrial, Tokyo, Japan] containing 500 mg ammonium sulfate, 500 mg L-glutamic acid, 100 mg sodium citrate, 1 mg pyridoxine, 0.5 mg biotin, 2.5 g disodium phosphate, 1 g monopotassium phosphate, 50 mg magnesium sulfate, 500 mg calcium chloride, 1 mg zinc sulfate, 850 mg NaCl, 5 g bovine serum albumin, 2 g dextrose, 3 mg catalase, and 500 mg Tween 80 per liter [pH 6.6 Ϯ 0.2]). M. tuberculosis strains were also incubated on egg-based Ogawa slant medium (Kyokuto Pharmaceutical Industrial) and Middlebrook 7H10 agar (BD Biosciences) containing 10% oleic acid-albumin-dextrose-catalase (OADC; BD Biosciences), 0.5% glycerol, and 0.05% Tween 80 (7H10/OADC).
MATERIALS AND METHODS

Ethics
Selection of hygromycin B-resistant mutants in vitro. Dilutions of Erdman cultures were spread onto 7H10/OADC plates containing 75 g/ml hygromycin B (Nacalai Tesque Inc.) and incubated at 37°C for 4 weeks. Isolated colonies were cultured in 7H9/ADC containing 75 g/ml hygromycin B for DNA sequencing.
Genotyping and genome sequencing of M. tuberculosis strain NCGM2242. Genomic DNA was extracted and fingerprinted with the probe IS6110 as described previously (13, 14) . Genomic DNA was sequenced using an Illumina Genome Analyzer IIx (Illumina Inc., CA) (12, 15) and analyzed using Maq (http://maq.sourceforge.net).
Complementation of the U1406A mutation. To generate pHI191(pMV261Zeo), the Zeo r gene driven by the MOP promoter of pMSG360Z (16) was amplified by PCR using Phusion high-fidelity DNA polymerase (New England BioLabs Japan, Tokyo, Japan) and the phosphorylated primers zeo-F and zeo-R (Table 1) . pMV261(Km r ) (17) was amplified by PCR using the nonphosphorylated primers pMV261-F and pMV261-R (Table 1) . These fragments were ligated, and pMV261Zeo(Km s Zeo r ) was generated. Next, an 8-kbp fragment (rv1314cϳogt) containing the rRNA operon (rrn, encoding rrs [16S rRNA], rrl [23S rRNA], and rrf [5S rRNA]) of the wild type was inserted into pMV261. Briefly, three PCR fragments were amplified using primers rrs1-F and rrs1-R for fragment 1 (3.2 kbp; 5= NotI and 3= XbaI digestion), rrs2-F and rrs2-R for fragment 2 (3.5 kbp; 5= XbaI and 3= HindIII-KpnI digestion), and rrs3-F and rrs3-R for fragment 3 (1.3 kbp; 5= KpnI and 3= HindIII digestion) ( Table 1) . Each fragment was digested with the appropriate restriction enzyme(s) and then ligated to the digested pMV261-based backbone plasmids (pMV261, pMV261/ fragment 2, and pMV261/fragment 1/2), respectively. Generated pMV261/fragment 1/2/3 (pHI362) and pMV261Zeo were digested with NotI and HindIII to produce the following fragments: 4.0 and 8.0 kbp from pHI362; 0.4 and 3.7 kbp from pMV261Zeo. Each digested fragment, 8.0 kbp of pHI362 and 3.7 kbp of pMV261Zeo, was ligated; pHI363(pMV261Zeo-rrsWT) was constructed.
M. tuberculosis NCGM2242 was grown on Ogawa slant medium for 3 to 4 weeks and transferred to 5 ml of 10% glycerol by using an inoculating loop blue (10 l; Thermo Fishier Scientific). The bacteria floating (0.5 ml) in a 2-mm cuvette (BM Equipment, Tokyo, Japan) were electroporated with 2 to 3 g of plasmid (pMV261Zeo or pMV261Zeo-rrsWT) by using a Bio-Rad Gene Pulser with settings of 2.5 kV, 25 mF, and 1,000 ⍀. After electroporation, the bacteria were added to 4 ml of MycoBroth, incubated overnight at 37°C with shaking, and harvested by centrifugation at 3,000 rpm for 20 min at 4°C. Transformants were selected by plating on 7H10/ OADC plates with 25 g/ml Zeocin (Thermo Fisher Scientific).
Antibiotic susceptibility tests. MICs of kanamycin (KM), streptomycin (SM), ethambutol (EB), isoniazid (INH), rifampin (RFP), levofloxacin (LVFX), ciprofloxacin (CPFX), and rifabutin (RBT) were determined using a drug susceptibility test kit for M. tuberculosis (BrothMIC MTB-1; Kyokuto Pharmaceutical Industrial). The MIC of hygromycin B (HYG) (44) and those that bind to IF-3 (the predicted binding sites of IF-3 are G791 and G793) (green). U1406A makes a base pair with U1495 (blue). The structure was based on the crystal structure of Thermus thermophilus 30S rRNA (PDB ID 1J5E) (19) and was developed using Coot (20) .
was determined by a broth dilution method using MycoBroth containing hygromycin B, according to the manufacturer's protocols for BrothMIC MTB-1.
Measurement of stress sensitivity. Bacterial sensitivities to acid, heat, lysozyme, hydrogen peroxide, and nitric oxide were measured as described previously (18) . For analysis of nutrient starvation, M. tuberculosis strains were grown to early log phase, collected by centrifugation, and washed with phosphate-buffered saline (PBS) supplemented with 0.05% Tyloxapol (Sigma-Aldrich Japan, Tokyo, Japan) (PBS-ty-6.6 [pH 6.6]). Cells were filtered using a 5-m Acrodisc (Nihon Pall, Japan), adjusted to 1 ϫ 10 7 CFU/ml in PBS-ty-6.6, and incubated at 37°C. CFU were determined by plating onto 7H10/OADC plates.
Infection of mice. Eight-week-old BALB/c and SCID mice were obtained from CLEA Japan, Tokyo, Japan. Bacteria were grown to mid-log phase in MycoBroth, washed twice with PBS, filtered through a 5-m Acrodisc, and adjusted to 10 5 to 10 7 CFU/ml, as previously described (11) . Mice were injected intravenously with 0.2 ml of bacterial suspension. For the group that received 2 ϫ 10 7 CFU/mouse, the suspensions were injected intraperitoneally into mice. Infected mice were euthanized, and spleen, liver, and lung homogenates were plated onto 7H10/OADC plates for counting CFU. The mice were housed in low-pressure isolators, with survival monitored daily.
Computer graphics of U1406A on helix 44 of 16S rRNA. U1406 was replaced with an A, based on the crystal structure of the 30S subunit from Thermus thermophilus (PDB ID 1J5E) (19) by using the program Coot (20) . The representation of the structure was created by using RasMol version 2.7.5.2 (http://www.RasMol.org).
qRT-PCR for measuring the 16S/17S rRNA ratio. Total RNA was purified from mid-log cultures of NCGM2242 and Erdman cells, and first-strand cDNA was synthesized as described previously (21) . The primer sets used to detect 5= immature, 5= mature, 3= immature, and 3= mature rRNA were rrsF-1/rrsR-1, rrsF-2/rrsR-1, rrsF-3/rrsR-2, and rrsF-3/rrsR-3, respectively (Table 1) . Real-time quantitative reverse transcription-PCR (qRT-PCR) was carried out with the Lightcycler 1.5 (Roche Japan, Kamakura, Japan) with a Sybr green PCR kit (Qiagen Japan, Tokyo, Japan). The thermal cycling conditions included an initial denaturation at 95°C for 15 min, followed by 40 cycles of denaturation at 98°C for 30 s, annealing at 54°C for 1 min, and extension at 72°C for 30 s. Fluorescence was measured during each extension step. Primer sequences used in this section are shown in Table 1 .
Ribosome population analysis. Ribosomes were prepared from NCGM2242 and Erdman cells as described elsewhere (22) with slight modifications. Briefly, mid-log-phase cultures in 7H9/ADC (optical density at 530 nm [OD 530 ] of 0.6) were harvested, suspended in buffer containing 20 mM Tris-HCl (pH 7.5), 100 mM NH 4 Cl, 10 mM Mg(OAc) 2 (Ac is an abbreviation for acetate here), and 3 mM dithiothreitol, and disrupted by bead-beating with Lysing Matrix B beads. The lysates were filtered through 0.22-mm filters, 4 l of DNase (Qiagen Japan) was added, and the samples were incubated for 10 min on ice. The samples were centrifuged twice at 20,000 ϫ g for 20 min, and the supernatants were centrifuged at 30,000 ϫ g for 30 min and again at 105,000 ϫ g for 2 h. The pellets were washed once and suspended in buffer containing 20 mM Tris-HCl (pH 7.5), 100 mM NH 4 Cl, 10 mM Mg(OAc) 2 . Ribosome fractions were analyzed by using the Agilent RNA 6000 Pico kit and Bioanalyzer 2100 apparatus (Agilent Technologies Japan, Tokyo, Japan) according to the manufacturer's protocols.
Proteomics analysis by LTQ-Orbitrap mass spectrometry. Cultures of NCGM2242 and Erdman cells were incubated in 7H9/ADC until midlog phase and washed once with PBS. Cell walls were disrupted by beadbeating with Lysing Matrix B beads, followed by centrifugation. Wholecell lysates from two separate biological replicates were analyzed using an LTQ Orbitrap-XL mass spectrometer (Thermo Fisher Scientific) equipped with an Advance ultra-high-performance liquid chromatography (UHPLC) system (AMR Inc., Tokyo, Japan), an HTS-PAL autosampler (CTC Analytics AG, Zwingen, Switzerland), an Advance Captive Spray Source (AMR Inc.), and an L-column microcolumn (L-C 18 ; 3 mm and 0.1 by 150 mm [Chemical Evaluation and Research Institute, Tokyo, Japan]). HPLC-grade water solutions containing 0.1% formic acid (pump A) and acetonitrile (pump B) were used as eluents at a flow rate of 500 nl/min, starting at 5% B with a linear gradient to 55% B over 120 min and a linear increase to 95% B until 125 min, with 95% B maintained until 135 min and the initial condition repeated for up to 150 min. Mass spectra for each sample were recorded twice using an Xcalibur data-dependent Top 3 tandem mass spectrometry (MS/MS) method (exclusion duration, 60 s) under the conditions for an electrospray ionization positive ion mode, gas flow rate of 0, auxiliary gas flow rate of 0, sweep gas flow rate of 0, spray voltage of 1. (m/z 445.120020) background peaks used as lock masses for the FT mass analyzer during measurements. Each result was analyzed with Proteome Discoverer software (Thermo Fisher Scientific) equipped with a Mascot search engine and a Sprot protein database to prepare a reject mass list from all search input data. LTQ-Orbitrap mass spectrometry analysis was repeated using the reject mass list. After the second analysis was finished, this step was repeated. All data resulting from 3 cycle analyses of each sample (n ϭ 2) were uploaded to i-RUBY software (Medical ProteoScope Co., Ltd., Kanagawa, Japan), equipped with a Mascot search engine and Swiss-Prot and NCBI protein databases for multivariate analysis of unique proteins. The proteomics data of detected proteins with maximum protein scores of Ն30 are summarized below in Table 3 , and all detected proteins are shown in Table S1 in the supplemental material. Mycolic acid analysis. Two independent biological cultures of NCGM2242 and Erdman were grown in 40 ml of MycoBroth to mid-log phase. They were harvested, washed once with PBS buffer, suspended in 10 ml of 10% KOH, and incubated at 100°C for 2 h. The pH was adjusted to below 2 with 6 N HCl. Three milliliters of benzene-methanol-sulfuric acid (10:20:1) was added, and the samples were incubated at 100°C for 2 h. Mycolic acids were extracted by addition of 1 ml of water and 4 ml of n-hexane and concentrated. We used 2,5 -dihydroxybenzoic acid (DHB) as the matrix for sample ionization. About 1 l of NaI solution (1 mg/ml dissolved in tetrahydrofuran [THF]) was precoated onto a matrix-assisted laser desorption ionization (MALDI) target plate, followed by pipetting of 1 l of the sample solution (1 mg/ml dissolved in THF) and DHB (10 mg/ml dissolved in THF) and drying in air. Samples were measured using MALDI spiral time of flight mass spectrometry (TOF-MS) (JEOL Ltd., Tokyo, Japan) (23), with a flight length of ca. 17 m and eight cycles of the spiral trajectory to achieve high resolving power. Briefly, ions were generated by irradiation with a N 2 laser (337 nm). An accelerating voltage of ϩ20 kV was used to analyze positive ions in the mass spectra. The masses of mycolic acids were calibrated with an internal calibration method using five peaks of polymethylmethacrylate (Agilent Technologies):
.7394). Self-calibration using moderately strong peaks assigned to mycolic acids as internal references was performed. The peak matching of the mycolic acids was judged from errors within 0.01 Da. The mass spectral data analysis was supported using Polymerix software (Sierra Analytics, Inc., Modesto, CA).
Production of anti-KsgA antibody and Western blotting. Rabbit polyclonal anti-KsgA antibody was raised against an internal peptide (amino acids 169 to 177 of M. tuberculosis KsgA) conjugated to keyhole limpet hemocyanin (Eurofins Genomics KK, Tokyo, Japan). The expression vector pMAL-c2X for a maltose-binding protein (MBP) fusion protein was purchased from New England BioLabs. To generate pMAL-c2X/ KsgA129-177, oligonucleotides KsgA129-177-sense and KsgA129-177-antisense (Table 1) were annealed, digested with EcoRI and XhoI (TaKaRa Bio Inc., Shiga, Japan), and ligated into pMAL-c2X. Serum raised against KsgA was preabsorbed with MBP bound to amylose resin (New England BioLabs) and affinity purified with MBP-KsgA129-177 bound to amylose resin. M. tuberculosis strains, including Erdman, NCGM2242, NCGM2242(pMV261Zeo), and NCGM2242(pMV261Zeo-rrsWT), were cultured in 7H9/ADC at 37°C for 4 days with shaking. Following centrifugation, pellets of each culture were resuspended and sonicated in lysis buffer (40 mM Tris base, 1.0% ASB-14 [Sigma-Aldrich], 7.0 M urea, 2.0 M thiourea; pH 10.4), equivalent to protein extraction reagent type 3 (C0731; Sigma-Aldrich). The samples were added to SDS sample buffer and electrophoresed on 12.5% SDS-polyacrylamide gels (e-PAGEL E-T12.5T [ATTO, Tokyo, Japan]) at 200 V for 60 min. The proteins were transferred electrophoretically to BioTrace NT membranes (Nihon Pall) at 72 mA for 60 min and blocked with 5% skim milk in Tris-buffered saline (TBS) containing 0.05% Tween 20 (TBST; Nacalai Tesque) overnight at 4°C. The membranes were incubated with anti-KsgA antibody in 5% skim milk in TBST for 4 h at room temperature, washed four times with TBST for 15 min each, and incubated with goat anti-rabbit IgGalkaline phosphatase (sc-2007; Santa Cruz Biotechnology) in 5% skim milk in TBST at room temperature for 30 min. The membranes were again washed four times with TBST for 15 min each and incubated with 5-bromo-4-chloro-3-indolylphosphate/nitroblue tetrazolium color development substrate (Promega Japan, Tokyo, Japan) in alkaline phosphatase buffer (100 mM Tris-HCl, 150 mM NaCl, and 1 mM MgCl 2 ; pH 9.0). Precision Plus protein dual-color standards were purchased from Nippon Bio-Rad Laboratories, Japan.
Statistics. Results were compared using Student's t test and a one-way analysis of variance (ANOVA), as appropriate, with these analyses performed using GraphPad Prism software (GraphPad Software, Inc., CA). The survival curves were plotted according to the Kaplan-Meier method and analyzed by log-rank test using StatMate III (ATMS Co., Ltd., Tokyo, Japan).
RESULTS
Selection of kanamycin-and hygromycin B-resistant mutants.
To isolate in vitro mutants resistant to both kanamycin and hygromycin B, in which the kanamycin binding site involves 3-aminoglucose (9, 24) (Fig. 1A) , we streaked the virulent M. tuberculosis Erdman strain onto 7H10/OADC plates containing 75 g/ml hygromycin B, which allowed us to isolate a mutant strain, NCGM2242, with kanamycin and hygromycin B MICs of 16 g/ml and Ͼ1,024 g/ml, respectively (Table 2 ). NCGM2242 and the parental Erdman strain had identical banding patterns on pulsed-field gel electrophoresis and IS6110 fingerprinting, indicating that the mutant did not contain a large-scale rearrangement (see Fig. S1 in the supplemental material). We therefore sequenced the NCGM2242 genome by using Genome Analyzer IIx, with 726,394 reads covering 197,666,477 bp. When we compared the NCGM2242 and Erdman sequences (12), we found a single base substitution, U1406A (U1398A Mtb ), on 16S rRNA. U1406A overlaps the binding sites of kanamycin and hygromycin B (Fig. 1A) , and it is consistent with the resistance phenotype of NCGM2242.
The U1406A mutation alters global protein expression. Since the ribosome is essential for protein translation, we performed proteomics analysis to determine whether the U1406A mutation affected protein synthesis. When whole-cell lysates of strain NCGM2242 and Erdman cultures in 7H9/ADC were subjected to LTQ-Orbitrap mass spectrometry, we identified 1,818 and 1,821 proteins, respectively (see Table S1 in the supplemental material). Compared with Erdman lysates, 71 proteins (3.9%) in NCGM2242 lysates showed a 2-fold-higher abundance, whereas 361 proteins (19.9%) showed a 2-fold-lower abundance (Table 3) . Proteins underexpressed in NCGM2242 included virulence factors such as AtpE (ATP synthase), EsxA (ESAT-6), EsxB (CFP-10), FbpA (Ag85A), FbpB (Ag85B), FbpC (Ag85C), NuoD (NADH oxidoreductase subunit D), and NuoE (NADH oxidoreductase subunit E) (see Table S1 ). When we assessed sigma factors and transcriptional regulators, which are considered to play important roles in NCGM2242 protein expression, we found that 23 regulatory proteins were underexpressed (Table 3 ) and 3 were overexpressed in NCGM2242 compared with Erdman, including 16S rRNA (adenine 1518 -N 6 /adenine 1519 -N 6 )-dimethyltransferase (KsgA), with 6.3-fold upregulation in NCGM2242 (Table 4; see also Table S1 ). These findings demonstrated that the U1406A mutation broadly affects protein expression.
The U1406A mutation impairs the ribosome maturation process. NCGM2242 contains the point mutation U1406A, which makes a base pair with U1495 (Fig. 1) . Three highly expressed, ribosome-binding proteins were classified as being in the information pathways category, including translation, ribosomal structure, and biogenesis (Table 4) : KsgA, translation initiation factor 3 (IF-3), and ribosome-binding factor A (RbfA). KsgA dimethylates A1518 and A1519 on helix 45 of rRNA, which is located close to U1406A (Fig. 1B) and acts as a checkpoint during ribosome biogenesis (25, 26) . IF-3 binds to G793 in 16S rRNA, located spatially next to A1518 (27) (Fig. 1B) , and is involved in the proper initiation of translation by increasing the accuracy of initiator tRNA selection (28, 29) and dissociating 70S ribosomes (30) . RbfA binds to helices 44 and 45, which contain U1406A, for efficient processing at the 5= end of the 16S rRNA (31) . KsgA, IF-3, and RbfA are therefore involved in the mid-late maturation of 30S subunits and the initiation of translation. Following transcription, the 5= and 3= ends of precursor 16S rRNA (17S rRNA) are independently cleaved by specific RNases to form mature 16S rRNA (31) . To determine whether U1406A affects ribosome biosynthesis, we measured the ratio of 17S to 16S rRNA from mid-log-phase cultures of NCGM2242 and Erdman in 7H9/ADC. We found that the ratios of both the 5= and 3= uncut ends were significantly higher in NCGM2242 than in Erdman ( Fig. 2A) , indicating that both RNase digestion processes are affected in NCGM2242.
To determine whether U1406A also affects the ribosome assembly process, a final step in ribosome biogenesis, we measured the amounts of ribosome and ribosomal subunits from NCGM2242 and Erdman cells growing in 7H9/ADC. We found that the number of 70S ribosomes was lower and the numbers of 30S and 50S ribosomal subunits were higher in NCGM2242 than in Erdman cells (Fig. 2B) . The 30S/70S ratios were 0.41 in NCGM2242 and 0.20 in Erdman. The 50S/70S ratios were 0.50 in NCGM2242 and 0.30 in Erdman. The higher ratios in NCGM2242 indicate that 70S ribosomes in these cells were more prone to dissociate.
Alteration of mycolic acid structure. Of the ϳ28 mycolic acid biosynthesis enzymes (32) , our proteomics analysis detected MMAS-3 (Rv0643c), MMAS-2 (Rv0644c), DesA2 (Rv1094), InhA (Rv1484), and AcpS (Rv2523c) ( Table 4) . We also detected the mycolyl-transferase complex, Ag85C (Rv0129c), Ag85B (Rv1886c), and Ag85A (Rv3804c) ( Table 4) . These 8 detected proteins were underexpressed in NCGM2242 compared with those in Erdman (Table 4) . Mycolic acids are major and specific components of the M. tuberculosis cell envelope and play a critical role in bacterial growth inside macrophages (33) . To determine whether alterations in the expression of these proteins affect mycolic acid structure, we extracted mycolic acid fractions from NCGM2242 and Erdman cultures and analyzed them by MALDI spiral-TOF-MS (Fig. 3A) . Compared with strain Erdman, the relative intensity of methoxy-mycolic acids decreased from 36.6% to 18.2% and the relative quantity of ketomycolic acids increased from 55.0% to 68.9% in NCGM2242 (Fig.  3B) . The decrease in methoxy-mycolic acids may be due to reduced expression of MMAS-3 (Table 4) , which catalyzes the O-methylation of the hydroxymycolic acid precursor to form methoxy-mycolic acid (32, 33) . The U1406A mutation affects growth and survival in various in vitro environments. NCGM2242 grew slightly more slowly in MycoBroth (Fig. 4) . We found that NCGM2242 was more susceptible to nutrient starvation and acidic environments (Fig. 5) . The numbers of viable NCGM2242 cells were lower than for Erdman after 8 days in PBS-tyloxapol (pH 6.6) and after day 1 and day 2 in phosphate-citrate buffer (pH 4.6) ( Fig. 5A and B) . NCGM2242 was also more sensitive to nitrosative stress but was equally susceptible to lysozyme and hydrogen peroxide (H 2 O 2 ) and slightly more resistant than Erdman to heating at 45°C for 6 h (Fig. 5C) .
Virulence attenuation by the U1406A mutation. NCGM2242 virulence was assessed by intravenously infecting immunocompetent BALB/c mice (Fig. 6A) . All mice infected with 2 ϫ 10 6 CFU of strain Erdman succumbed to infection within 100 days (mean survival time [MST], 74.6 Ϯ 15.7 days [Ϯ the standard deviation]), whereas 9 of 10 mice infected with 2 ϫ 10 6 CFU NCGM2242 survived during the observation period (P Ͻ 0.0001), with the mycobacterial CFU isolated from the spleens, livers, and lungs of these mice decreasing after 43 days (Fig. 6B to D) . To and NCGM2242(pMV261Zeo) (mock) were identical in 7H9/ ADC. NCGM2242(pMV261Zeo-rrsWT) grew slightly more slowly than other strains (Fig. 7A ). As shown in Table 2 , NCGM2242(pMV261Zeo-rrsWT) was still resistant to kanamycin, because the strain had both the wild-type rrs gene on the plasmid and the gene with the U1406A mutation on the chromosome. Thus, the chromosomal ribosome may continue to function in the presence of 2 g/ml kanamycin, the MIC for strain Erdman. Compared with Erdman, NCGM2242 and NCGM2242(pMV261Zeo) were slightly more susceptible to INH (Table 2) , which may have been due to the lower expression of InhA in NCGM2242 (Table 4 ). The complementation strain restored the MIC of INH.
Proteomics analysis showed that ribosomal protein KsgA, which dimethylates A1518 and A1519, both spatially located close to the mutation site of NCGM2242 (Fig. 1B) , was highly expressed in NCGM2242 (Tables 3 and 4; see also Table S1 in the supplemental material). To confirm ribosome complementation, KsgA expression was measured in strains Erdman, NCGM2242, NCGM2242(pMV261Zeo), and NCGM2242 (pMV261Zeo-rrsWT) by immunoblotting with anti-KsgA antibody. A band of approximately 37 kDa, close to the 35.2-kDa predicted molecular mass of KsgA, was detected in all four strains, with the amounts being more than 3-fold higher in NCGM2242 and NCGM2242(pMV261Zeo) than in Erdman and NCGM2242 (pMV261Zeo-rrsWT) (Fig. 7B) . These results indicated that complementation with the rRNA operon of the wild type (rrs at position 1406 is U) restored the level of KsgA expression of NCGM2242.
The complementation was also assessed by counting CFU from spleens, livers, and lungs of intravenously infected BALB/c mice. Bacterial CFU counts in the spleens, livers, and lungs are shown in Fig. 7C . Whereas NCGM2242(pMV261Zeo)-infected mice had significantly fewer CFU in the spleen, liver, and lung than Erdman-infected mice at day 94, no significant differences in bacterial loads were observed between Erdman-infected versus NCGM2242(pMV261Zeo-rrsWT)-infected mice. This indicated that the mycobacterial CFU isolated from spleens, livers, and lungs were recovered by the complementation of the rRNA operon of the wild type.
DISCUSSION
Since anti-M. tuberculosis drugs target essential cellular functions, it might be expected that resistance mutations in target-encoding genes will impact the viability of M. tuberculosis as well as its pathogenesis. Therefore, the mutations associated with drug resistance tend to be restricted to a small number of single nucleotide polymorphisms (SNP). For example, about 56% of kanamycin-resistant strains have a mutation on rrs A1401G, while other rrs mutations were found in less than 10% of the strains (35) . The fitness cost of resistance has been identified as a critical determinant of the spread of drug-resistant M. tuberculosis strains (36) . However, most studies have estimated fitness cost based on growth rate under in vitro conditions. Therefore, the contribution of rrs mutations for pathogenesis remains poorly understood. Here, we show the significant difference of fitness cost of the rrs mutation between in vivo and in vitro conditions. The U1406A mutation on the rrs gene likely attenuates the pathogenicity of NCGM2242 in a pleiotropic manner. Although the factors that attenuate the pathogenicity of NCGM2242 against BALB/c and SCID mice were not determined in this study, three factors related to the virulence and viability of M. tuberculosis were different between NCGM2242 and Erdman. First, the protein expression of virulence factors, including antigen 85 complexes and ESAT-6, was lower in NCGM2242. Second, NCGM2242 had reduced viabilities under both nutrient starvation and acidic conditions, which may be caused by the downregulation of enzymes involved in central metabolism, including AtpE, NuoD, and NuoE. Third, mycolic acid composition was altered in NCGM2242, with increases in methoxy-mycolic acids and con-comitant decreases in keto-mycolic acids, due to the lower expression of these enzymes in mycolic acid biosynthesis, including MMAS-3.
The decreased MIC of INH, the increased level of KsgA expression, and the attenuation of pathogenicity in mice of NCGM2242 (the rrs U1406A mutant) were restored by complementation with the wild-type rRNA operon. However, the growth rate in vitro was slightly lower in the complementation strain. The complementation strain had one chromosomal rrs U1406A gene and multiple rRNA operons, including wild-type rrs on the plasmid (pMV261 derivative, with 3 to 5 copies in mycobacteria) (17) . In general, rRNA operon copy number correlates with the in vitro growth rate of prokaryotic organisms (37) . However, extra rRNA operons on a plasmid reduced the growth rate in E. coli while concomitantly increasing stable rRNA concentrations, indicating a potential cost associated with constitutive expression from multiple rRNA operons at a low growth rate (38) . Further study is needed to understand the effect of extra rRNA operons in vivo and the molecular mechanisms of attenuation by the U1406A mutation.
Mutations in the decoding regions of 16S rRNA induce misreading errors. To our knowledge, no E. coli strain with the U1406A mutation has been observed in fitness cost studies. However, the in vitro-generated C1407U mutation in the E. coli rrs gene, at the nucleotide next to the U1406A mutation, induced misreading errors (39) but has not been found among kanamycinresistant clinical M. tuberculosis isolates. It is suggested that three ribosome maturation-related proteins, KsgA, IF-3, and RbfA, are overexpressed in NCGM2242 to minimize the impaired decoding process in NCGM2242 and consequently maintain translational fidelity. These three proteins have been reported to be related to translational fidelity in E. coli (26, (39) (40) (41) (42) (43) . The kasugamycin-resistant E. coli mutant ⌬ksgA shows an accumulation of 17S rRNA and free 30S particles at low temperatures (26) , with increased decoding errors during elongation (40) and enhanced initiation from non-AUG codons (39) . The E. coli mutant ⌬rbfA shows an accumulation of 17S rRNA (41, 42) . IF-3 is important in controlling tRNA association and dissociation onto the ribosome, selecting the correct tRNA and initiating elongation from the correct start codon (43) .
In summary, this study provides a new insight into the reason why the variety of mutations conferring drug resistance among the clinical isolates is smaller than that isolated from in vitro environments. A fitness cost study based on the infection model will provide a deeper understanding of clinical spread of drug-resistant M. tuberculosis.
